- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Most Popular Stocks
Hong Kong Pharmaceuticals & Biotech Most Popular Stocks
Results
132
Most Popular Stocks on the market
132 companies
Hansoh Pharmaceutical Group
Market Cap: HK$198.4b
An investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.
3692
HK$32.72
7D
-9.7%
1Y
-8.1%
WuXi Biologics (Cayman)
Market Cap: HK$192.9b
An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, Australia, and Brazil.
2269
HK$47.00
7D
-4.4%
1Y
28.8%
Innovent Biologics
Market Cap: HK$162.9b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.
1801
HK$93.55
7D
-8.6%
1Y
-4.4%
Sichuan Kelun-Biotech Biopharmaceutical
Market Cap: HK$111.2b
A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, metabolism, and other therapeutic areas in the People’s Republic of China and internationally.
6990
HK$465.20
7D
-4.9%
1Y
-8.2%
CSPC Pharmaceutical Group
Market Cap: HK$99.6b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
1093
HK$8.71
7D
-10.1%
1Y
-15.8%
Sino Biopharmaceutical
Market Cap: HK$93.5b
An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.
1177
HK$5.25
7D
-5.1%
1Y
-39.2%
WuXi XDC Cayman
Market Cap: HK$91.3b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$72.10
7D
-1.0%
1Y
6.9%
Akeso
Market Cap: HK$83.2b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.
9926
HK$90.30
7D
-10.8%
1Y
-33.4%
Genscript Biotech
Market Cap: HK$70.8b
An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
1548
HK$32.36
7D
2.9%
1Y
86.2%
RemeGen
Market Cap: HK$62.8b
A biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States.
9995
HK$73.75
7D
-7.8%
1Y
-32.6%
Biocytogen Pharmaceuticals (Beijing)
Market Cap: HK$53.5b
A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.
2315
HK$56.10
7D
-7.4%
1Y
143.9%
3SBio
Market Cap: HK$38.5b
An investment holding company, engages in the development, production, marketing, and sale of biopharmaceutical products in the People’s Republic of China, the United States, and internationally.
1530
HK$15.44
7D
-4.9%
1Y
-52.6%
Shanghai Henlius Biotech
Market Cap: HK$34.2b
Engages in the research and development of biologic medicines with a focus on oncology, autoimmune diseases, and ophthalmic diseases.
2696
HK$63.00
7D
-10.1%
1Y
-20.8%
Shanghai Junshi Biosciences
Market Cap: HK$32.2b
A biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in China.
1877
HK$16.60
7D
-8.9%
1Y
-50.8%
XtalPi Holdings
Market Cap: HK$29.8b
Operates as a research platform company in Mainland China, the United States, and internationally.
2228
HK$6.93
7D
-5.5%
1Y
-32.2%
InSilico Medicine Cayman TopCo
Market Cap: HK$29.1b
Engages in applying artificial intelligence (AI) solutions to drug discovery and development by leveraging its proprietary platforms.
3696
HK$50.50
7D
3.6%
1Y
n/a
Simcere Pharmaceutical Group
Market Cap: HK$28.4b
An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China.
2096
HK$11.05
7D
-5.0%
1Y
-20.8%
InnoCare Pharma
Market Cap: HK$27.6b
A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.
9969
HK$13.54
7D
-11.9%
1Y
-29.4%
China Resources Pharmaceutical Group
Market Cap: HK$26.7b
An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$4.25
7D
-4.2%
1Y
-15.0%
China Medical System Holdings
Market Cap: HK$26.2b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$10.78
7D
-2.4%
1Y
-30.2%
Keymed Biosciences
Market Cap: HK$21.5b
A biotechnology company, engages in the discovery and development of biological therapies in the autoimmune and oncology therapeutic areas in Mainland China, the United States, and the United Kingdom.
2162
HK$73.05
7D
-8.4%
1Y
-3.8%
Sunshine Lake Pharma
Market Cap: HK$21.3b
Engages in the research, development, manufacture, and sale of pharmaceutical products for the treatment of infectious diseases, chronic diseases, and oncology.
6887
HK$36.96
7D
-1.4%
1Y
-30.4%
Metis TechBio
Market Cap: HK$18.2b
Engages in research and development of AI-empowered nanomaterial for the delivery and application of active agents across carbon-based life forms in Chinese Mainland and United States.
7666
HK$15.42
7D
11.6%
1Y
n/a
Grand Pharmaceutical Group
Market Cap: HK$16.6b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
512
HK$4.74
7D
-3.6%
1Y
-47.0%
United Laboratories International Holdings
Market Cap: HK$15.7b
An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.
3933
HK$7.94
7D
-5.0%
1Y
-51.6%
Duality Biotherapeutics
Market Cap: HK$15.3b
A clinical-stage biopharmaceutical company, discovers and develops antibody-drug conjugate (ADC) therapeutics to treat cancer, autoimmune diseases, and others in China and internationally.
9606
HK$168.70
7D
-6.6%
1Y
-62.6%
Fujian Haixi Pharmaceuticals
Market Cap: HK$15.2b
Engages in research and development, production, and sale of pharmaceutical products in China.
2637
HK$193.00
7D
-3.2%
1Y
n/a
Vigonvita Life Sciences
Market Cap: HK$12.6b
A biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule drugs for neuropsychiatry, reproductive health, and viral infection therapeutic areas.
2630
HK$75.00
7D
-21.1%
1Y
n/a
CanSino Biologics
Market Cap: HK$11.9b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$25.80
7D
-11.7%
1Y
-52.5%
Nanjing Leads Biolabs
Market Cap: HK$11.7b
A clinical-stage biotechnology company, engages in the research, development, and commercialization of novel antibody drugs worldwide.
9887
HK$60.20
7D
-5.9%
1Y
-8.4%
Ascentage Pharma Group International
Market Cap: HK$11.5b
A clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China.
6855
HK$31.38
7D
-10.3%
1Y
-60.4%
Ab&B Bio-Tech JS
Market Cap: HK$11.5b
Ab&B Bio-Tech CO., LTD. JS researchs, develops, manufactures, and sells vaccines and biological preparations that provide active immunity against diseases.
2627
HK$29.32
7D
0%
1Y
n/a
HBM Holdings
Market Cap: HK$11.2b
A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.
2142
HK$12.89
7D
-12.4%
1Y
-21.3%
Consun Pharmaceutical Group
Market Cap: HK$10.9b
Produces and sells pharmaceutical products in Mainland China.
1681
HK$13.04
7D
-4.2%
1Y
-18.4%
Ascletis Pharma
Market Cap: HK$10.0b
A biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China.
1672
HK$9.45
7D
-6.3%
1Y
-15.2%
GenFleet Therapeutics (Shanghai)
Market Cap: HK$9.4b
A biopharmaceutical company, develops treatment options in the fields of oncology, autoimmune, and inflammatory diseases in the United States.
2595
HK$25.48
7D
-7.3%
1Y
n/a